DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,364	1,658	4,350	3,125	4,002	3,410
Short-Term Investments	3,300	5,100	7,620	3,240	11,340	5,970
Trading Asset Securities	2,267	1,104	1,489	1,597	3,080	2,979
Cash & Short-Term Investments	7,931	7,863	13,458	7,962	18,422	12,360
Cash Growth	-48.08%	-41.58%	69.03%	-56.78%	49.05%	3.85%
Accounts Receivable	22,613	20,383	22,755	18,137	16,719	16,317
Other Receivables	897.56	1,006	1,422	1,313	1,517	1,696
Receivables	23,511	21,389	24,176	19,450	18,236	18,013
Inventory	32,160	31,340	26,678	23,413	18,682	19,713
Prepaid Expenses	589.86	480.34	310.27	294.59	287.91	178.3
Other Current Assets	180.27	534.76	597.23	92.92	511.03	661.91
Total Current Assets	64,372	61,607	65,220	51,213	56,139	50,926
Property, Plant & Equipment	85,078	91,702	94,351	89,857	68,245	68,778
Long-Term Investments	3,823	3,798	10,929	10,475	8,639	13,819
Goodwill	693.16	693.16	693.16	693.16	693.16	2,124
Other Intangible Assets	28,995	28,630	27,822	26,972	23,775	19,762
Long-Term Deferred Tax Assets	3,459	3,622	3,992	3,642	4,172	3,734
Other Long-Term Assets	19,968	15,831	16,154	16,204	15,713	15,904
Total Assets	206,388	205,884	219,163	199,056	177,376	175,047
Accounts Payable	14,245	11,597	15,783	12,925	8,026	8,048
Accrued Expenses	2,581	2,559	2,669	2,958	1,504	1,129
Short-Term Debt	61,989	59,199	74,457	59,055	56,347	56,957
Current Portion of Long-Term Debt	32,228	34,238	28,189	3,250	2,500	750.63
Current Portion of Leases	129.8	117.78	149.65	201.76	238.02	307.79
Current Income Taxes Payable	160.9	46.26	27.35	380.05	1,463	560.87
Current Unearned Revenue	42.35	42.35	42.35	50.19	69.05	67.22
Other Current Liabilities	9,098	9,893	6,631	4,440	5,189	9,787
Total Current Liabilities	120,473	117,693	127,948	83,260	75,335	77,608
Long-Term Debt	5,856	5,566	7,500	27,307	10,796	5,249
Long-Term Leases	168.16	151.94	229.92	251.93	269.24	291.61
Pension & Post-Retirement Benefits	3,449	3,770	3,676	3,275	4,402	2,655
Other Long-Term Liabilities	2,715	2,334	2,457	3,271	3,157	3,091
Total Liabilities	132,661	129,515	141,809	117,365	93,960	88,894
Common Stock	9,308	9,308	9,308	9,308	9,308	9,285
Additional Paid-In Capital	35,083	33,023	33,023	33,023	33,023	32,078
Retained Earnings	35,231	39,383	41,562	45,862	46,529	46,807
Treasury Stock	-9,162	-9,162	-9,162	-9,162	-9,162	-9,162
Comprehensive Income & Other	-1,634	-554.04	-1,500	-1,040	-24.6	2,971
Total Common Equity	68,826	71,999	73,232	77,993	79,674	81,979
Minority Interest	4,901	4,371	4,121	3,699	3,742	4,173
Shareholders' Equity	73,727	76,370	77,353	81,691	83,416	86,152
Total Liabilities & Equity	206,388	205,884	219,163	199,056	177,376	175,047
Total Debt	100,371	99,274	110,525	90,066	70,150	63,556
Net Cash (Debt)	-92,439	-91,411	-97,067	-82,104	-51,728	-51,197
Net Cash Per Share	-5273.75	-5218.53	-5541.39	-4687.19	-2962.69	-2957.90
Filing Date Shares Outstanding	17.86	17.52	17.52	17.52	17.52	17.47
Total Common Shares Outstanding	17.86	17.52	17.52	17.52	17.52	17.47
Working Capital	-56,101	-56,085	-62,728	-32,047	-19,196	-26,681
Book Value Per Share	3854.25	4110.33	4180.70	4452.48	4548.48	4692.74
Tangible Book Value	39,138	42,676	44,717	50,327	55,206	60,093
Tangible Book Value Per Share	2191.72	2436.30	2552.81	2873.10	3151.65	3439.93
Land	-	18,964	19,097	19,097	19,097	19,097
Buildings	-	67,440	67,144	45,065	45,065	45,065
Machinery	-	62,371	56,983	42,936	44,633	44,017
Construction In Progress	-	470.04	2,765	29,549	3,035	594.6

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.